- cross-posted to:
- [email protected]
- cross-posted to:
- [email protected]
Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.
We need to shorten the term for patents and make patent extension more difficult for this reason alone.